Environmental scan of provincial and territorial planning for COVID-19 vaccination programs

Author:

MacDonald Shannon E.ORCID,Sell Hannah,Wilson Sarah,Meyer Samantha B.,Gagneur Arnaud,Assi Ali,Sadarangani Manish,

Abstract

AbstractBackgroundPublic health departments in Canada are currently facing the challenging task of planning and implementing COVID-19 vaccination programs.ObjectiveTo collect and synthesize information regarding COVID-19 vaccination programs in each of the provinces and territories (P/Ts).MethodsProvincial/territorial public health leaders were interviewed via teleconference between August-October 2020 to collect information on the following topics, drawn from scientific literature and media: unique factors for COVID-19 vaccination, adoption of National Advisory Committee on Immunization (NACI) recommendations, priority groups for early vaccination, and vaccine safety and effectiveness monitoring. Data were grouped according to common responses and descriptive analysis was performed.ResultsEighteen interviews occurred with 25 participants from 11 of 13 P/Ts. Factors unique to COVID-19 vaccination included prioritizing groups for early vaccination (n=7), public perception of vaccines (n=6), and differing eligibility criteria (n=5). Almost all P/Ts (n=10) reported reliance on NACI recommendations. Long-term care residents (n=10) and health care workers (n=10) were most frequently prioritized for early vaccination, followed by people with chronic medical conditions (n=9) and seniors (n=8). Most P/Ts (n=9) are planning routine adverse event monitoring to assess vaccine safety. Evaluation of effectiveness was anticipated to occur within public health departments (n=3), by researchers (n=3), or based on national guidance (n=4).ConclusionPlans for COVID-19 vaccination programs in the P/Ts exhibit some similarities and are largely consistent with NACI guidelines, with some discrepancies. Further research is needed to evaluate the success of COVID-19 vaccination programs once implemented.

Publisher

Cold Spring Harbor Laboratory

Reference9 articles.

1. Government of Canada. Pfizer-BioNTech COVID-19 Vaccine (tozinameran) [Internet]. Ottawa (ON): Government of Canada; 2020 Dec 9 [updated 2020 Dec 11; cited 2020 Dec 11]. Available from: https://covid-vaccine.canada.ca/pfizer-biontech-covid-19-vaccine/product-details

2. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations;Expert Rev Vaccines,2020

3. Key populations for early COVID-19 immunization: preliminary guidance for policy

4. National Advisory Committee on Immunization. Guidance on the prioritization of initial doses of COVID-19 vaccine(s) [Internet]. Ottawa (ON): Government of Canada; 2020 [updated 2020 Dec 4; cited 2020 Dec 14]. Available from: https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-prioritization-initial-doses-covid-19-vaccines.html

5. Frank K , Arim R. Canadians’ willingness to get a COVID-19 vaccine: Group differences and reasons for vaccine hesitancy [Internet]. Ottawa (ON): Statistics Canada; 2020 Aug 25 [cited 2020 Dec 11]. Available from: https://www150.statcan.gc.ca/n1/pub/45-28-0001/2020001/article/00073-eng.htm

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3